Cargando…
Liver dysfunction in COVID-19: a useful prognostic marker of severe disease?
BACKGROUND: COVID-19 is a global pandemic caused by the novel coronavirus SARS-CoV-2. Risk factors and prognostic markers of severe disease remain to be fully determined, although some studies have suggested a correlation between abnormal liver function and adverse outcomes. Further studies are need...
Autores principales: | Lok, James, Gess, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231420/ https://www.ncbi.nlm.nih.gov/pubmed/34249314 http://dx.doi.org/10.1136/flgastro-2020-101689 |
Ejemplares similares
-
Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018) -
Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales
por: Yeoman, Andrew, et al.
Publicado: (2020) -
Network and satellite arrangements in liver disease
por: O'Grady, John G
Publicado: (2013) -
Non-alcoholic fatty liver disease: a practical approach to treatment
por: Dyson, J K, et al.
Publicado: (2014) -
Patient understanding of liver cirrhosis and improvement using multimedia education
por: Goldsworthy, Matthew A, et al.
Publicado: (2017)